参考资料:1.Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis 2015;9:e0003832.2. Merrell DS, Butler SM, Qadri F, et al. Host-induced epidemic spread of the cholera bacterium. Nature 2002; 417:642.3. Hartley DM, Morris JG Jr, Smith DL. Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med2006; 3:e7.4. Mosley WH, Benenson AS, Barui R. A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibodyin the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemiccholera. Bull World Health Organ 1968; 38:327.5. Hirschhorn N, Chowdhury AK, Lindenbaum J. Cholera in pregnant women. Lancet 1969; 1:1230.6.World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. -- 4th revision. WHO/FCH/CAH/05.1. Geneva: World Health Organization, 2005. http://whqlibdoc.who.int/publications/2005/9241593180.pdf (Accessed on January 08, 2010).7. Pruzzo C, Vezzulli L, Colwell RR. Global impact of Vibrio cholerae interactions with chitin. Environ Microbiol 2008; 10:1400.8. Huq A, Xu B, Chowdhury MA, et al. A simple filtration method to remove plankton-associated Vibrio cholerae in raw watersupplies in developing countries. Appl Environ Microbiol 1996; 62:2508.9. Glass RI, Svennerholm AM, Stoll BJ, et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl JMed 1983; 308:1389.10. Harris JB, LaRocque RC, Chowdhury F, et al. Susceptibility to Vibrio cholerae infection in a cohort of household contacts ofpatients with cholera in Bangladesh. PLoS Negl Trop Dis 2008; 2:e221.11.《2020年霍乱年报》,《疫情周报》,第37期,2021年9⽉,第96卷,(第445-460⻚)。12.《霍乱疫苗:世卫组织⽴场⽂件》— 2017年8⽉http://apps.who.int/iris/bitstream/10665/258764/1/WER9234-477-498.pdf《疫情周报》,2017年8⽉25⽇,第34期,2017年,第92卷,第477-500⻚。